According to Chris Calhoun, CEO of San Diego-based biotech company Cytori Therapeutics, leading to medical breakthroughs in tissue engineering is not on that list. As you may know, breasts are mostly made of adipose (fat) tissue. But what I personally didn’t know is that that adipose tissue is loaded with useful stem cells capable enhancing, healing, and rebuilding injured or damaged organs.
As Calhoun puts it:
“It’s the first practical cell therapy.” He pauses. “And it’s breasts.”
His plan is to put stem cells from breasts on the market to get around the public controversy over embryonic stem cells.
- Breasts and the future of regenerative medicine (sentientdevelopments.com)
- Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair (eon.businesswire.com)